ストックスクリーナーアプリを入手
4.43
1.77%
-0.08
Clene Inc (CLNN) 最新ニュース
Clene Inc. (NASDAQ:CLNN) Short Interest Up 10.3% in January - Defense World
Nanotechnology Stocks To ResearchFebruary 13th - MarketBeat
Could a New Drug Help Restore Vision? Early Findings in Myelin Repair - Securities.io
7 Best Nanotech Penny Stocks to Invest In - Insider Monkey
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? - Insider Monkey
Nanotechnology Stocks To Watch TodayFebruary 09th - MarketBeat
Promising Nanotechnology Stocks To Follow TodayFebruary 11th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnFebruary 08th - MarketBeat
Critical LDAP Vulnerability Puts Windows Systems at Risk - Experts' club
Best Nanotechnology Stocks To Watch NowFebruary 07th - MarketBeat
Promising Nanotechnology Stocks To Watch TodayFebruary 06th - MarketBeat
Nanotechnology Stocks To Follow NowFebruary 05th - MarketBeat
Promising Nanotechnology Stocks To Watch Today – February 06th - Armenian Reporter
Nanotechnology Stocks To Add to Your WatchlistFebruary 04th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy - MSN
Promising Nanotechnology Stocks To Keep An Eye OnJanuary 31st - MarketBeat
Best Nanotechnology Stocks To Follow TodayJanuary 30th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy By Investing.com - Investing.com UK
NATR Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus.com
Clene files to sell 1.15M shares of common stock by selling shareholders - MSN
Clene (CLNN) Stock Price, News & Analysis - MarketBeat
3 US Growth Stocks With High Insider Ownership And Revenue Growth Up To 25% - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS - Nasdaq
Clene Secures $10 Million Debt Facility to Advance ALS Drug Development - Citybuzz
Clene (NASDAQ: CLNN) Paves Cash Runway To Advance CNM-Au8(R) For ALS - Barchart
3 US Growth Stocks With High Insider Ownership - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - Yahoo Finance
Clene Receives FDA Guidance on Potential Accelerated Approval Pathway for ALS Drug CNM-Au8 - Citybuzz
Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - The Globe and Mail
Clene Secures $10M Debt Facility to Enhance Position - TipRanks
Clene Secures $10 Million Debt Facility to Advance ALS and Neurodegenerative Disease Treatments - Citybuzz
IBN Coverage: Clene (NASDAQ: CLNN) Secures $10M Debt Facility to Advance Neurodegenerative Disease Treatments - Yahoo Finance
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan - The Manila Times
Real-World Evidence Helps Open Accelerated Approval Pathway For Neurodegeneration Therapies - News & Insights
Clene Inc. Provides Update on Corporate Presentation and ALS Clinical Trials - Defense World
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway - Yahoo Finance
Clene Receives FDA Guidance on Accelerated Approval Path for ALS Treatment CNM-Au8 - Citybuzz
Clene Gains FDA Support for ALS Treatment Approval - TipRanks
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS - The Manila Times
FDA Opens Accelerated Approval Path for Clene's Breakthrough ALS Treatment After 78% Survival Benefit - StockTitan
Clene (NASDAQ:CLNN) Given New $84.00 Price Target at Benchmark - Defense World
Clene shares hold Buy rating as analyst sees FDA decision impacting time to market - Investing.com
Roth Capital Has Bearish Forecast for Clene FY2024 Earnings - Defense World
Clene (NASDAQ:CLNN) Price Target Lowered to $83.00 at Canaccord Genuity Group - Defense World
HC Wainwright Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
AWM Investment Company, Inc. Expands Stake in Clene Inc - GuruFocus.com
Clene price target lowered to $83 from $86 at Canaccord - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires New Stake in Clene Inc - GuruFocus.com
Certain Warrants of Clene Inc. are subject to a Lock-Up Agreement Ending on 15-NOV-2024. - Marketscreener.com
Clene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
1.60%
2.53%
大文字化:
|
ボリューム (24 時間):